| 1 |
What is the primary application of machine learning (ML) in the field of drug discovery?
|
E) Automating the drug packaging process |
|
Machine learning takes input information and makes decisions faster to accelerate DMTA cycle of novel molecular entities.
|
ML helps to produce drugs in a way that saves resources and time.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What is QSAR in the context of drug discovery?
|
C) A machine learning approach to predict the activity of compounds |
|
QSAR necessary component of numerous drug discovery projects.
|
It will help to predict the bioactivity and physical properties of machines in order to produce drugs.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is data preparation critical in the model life cycle of ML for drug discovery?
|
B) It ensures the reliability of data for model training |
|
Performance heavily relies on the quality of the experimental data used for training.
|
The model life cycle displays data preparation, constitutes the actual model design and building process, performance validation of the model, and the model deployment phase, which makes it more reliable.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is a major challenge when using public data sets in drug discovery ML models?
|
C) Heterogeneity and varying quality of data |
|
It bears the risk of biases, redundancies, and error accumulation.
|
This poses challenges in both academic and industrial settings.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
How does time-split data validation benefit the predictive performance of ML models in drug discovery?
|
E) By facilitating regulatory approval processes |
|
|
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Which aspect is NOT a direct benefit of AI as perceived by dermatologists for improving the melanoma diagnosis process?
|
B) Increasing the diagnostic accuracy through pattern recognition |
|
Dermatologists have said that AI has aided in providing information for patient diagnoses, however, it has not been proven to be more accurate.
|
AI gathers information, does examinations and tests, assesses and diagnoses, comes up with a treatment plan, and monitors and gives feedback to the patient.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
What is the primary reason dermatologists want scientific proof of AI's validity for diagnosis?
|
E) To gain confidence in AI-assisted diagnostic decisions |
|
Dermatologists believe that AI can assist but never become the one who makes the final diagnosis.
|
They were worried about their patients' safety and believed that they could only use AI to assist in diagnosing patients. They believe that AI is not fully trustable and they would always need to use rationality in making decisions along with AI.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
Which of the following is identified as a challenge introduced by AI in the diagnostic process?
|
A) Simplifying medical terminology for patients |
|
They were worried about how AI would communicate the diagnosis to their patients.
|
Dermatologists say that their patients would want to discuss every little detail about their diagnosis, but AI may not be able to do that and they were thinking how patients may be reluctant of accepting AI as a source of diagnosis.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How do dermatologists perceive the final responsibility for a medical diagnosis when AI is used?
|
B) It is shared between AI and medical professionals |
|
They believe that AI can assist in making medical diagnoses, however, they must use their own judgment as well.
|
AI can aid in saving time when diagnosing patients for physicians, however, it may be incorrect or not the best option, so they must use their judgment and pick what they think is safest for the patient.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is essential for dermatologists to effectively utilize AI in diagnosing melanoma?
|
E) AI's ability to operate independently without human input |
|
Dermatologists want the assurance that AI would be able to come up with good diagnoses on their own.
|
Many junior dermatologists would rely on the AI predictions instead of listening to their own judgment, which could be risky.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What factor is crucial for the accuracy of a machine learning model in predicting drug efficacy?
|
C) The quality and relevance of the training data |
|
The data they feed into the machine will aid in drug efficacy.
|
ML model performance heavily relies on the quality of the experimental data used for training.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
How does collaboration between academia and industry contribute to advancements in drug discovery using machine learning?
|
C) By combining diverse expertise and resources |
|
Combining academia and industry would result in diverse expertise and resources.
|
Industry uses a model to assist in drug design, and academia focuses on theory and method development. These two combine diverse expertise and resource which would contribute to advancements in drug discovery using ML.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is a significant challenge in deploying machine learning models for drug discovery in a real-world scenario?
|
E) Too much available data |
|
The selection of the modeling approach is influenced by the available data set size and composition.
|
Models based on data sets with broader chemical space coverage usually generalize better.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Why is model validation using a time-split approach considered effective in the context of drug discovery?
|
B) It more accurately reflects the model's predictive performance on future, unseen data |
|
Time splits have emerged as a preferred approach in the industry to evaluate the prospective model performance.
|
The time-split approach mimics how an ML model will be used in practice, such as predicting compounds that have not been synthesized or measured.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
In the context of drug discovery, what is the primary benefit of using machine learning models that can quantify prediction uncertainty?
|
C) They provide insights into the reliability of predictions, aiding in risk assessment and decision-making |
|
|
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Considering the ethical implications of AI in medical diagnosis, which factor is most crucial for ensuring responsible AI use?
|
B) Prioritizing AI's autonomous decision-making |
|
AI's decision-making must be correct in order to ensure patient safety.
|
If the AI's decision is wrong and there is no physician to help judge, it can result in harm to the patient instead of being helpful, so AI's autonomous decision-making should be priortitized.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
In the context of human-AI collaboration in medical diagnosis, what is the primary challenge in integrating AI into clinical practice according to the article?
|
D) Ensuring AI can fully replace human judgment |
|
AI can assess patients which would be a good support to physicians, however, it may be inaccurate which can be the cause of why it cannot fully replace human judgment.
|
If an AI's diagnosis is wrong and there is no human to judge, it can lead to harm, therefore they must ensure that AI can make accurate diagnoses to be able to fully replace human judgment.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What do dermatologists view as the potential benefit of AI in improving melanoma diagnosis?
|
B) Completely automating the diagnostic process |
|
AI can save time and money for the patient by diagnosing the patient for melanoma on its own.
|
AI can handle a big volume of data and it can scan and analyze the patient's whole body to detect melanoma which would be a great support and save time for physicians.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Why is scientific proof of AI's validity crucial for its acceptance among dermatologists?
|
D) It builds trust and confidence in AI's diagnostic recommendations |
|
Dermatologists are skeptical about the accuracy of AI's diagnosis.
|
If there is scientific proof that AI can diagnose patients accurately, it would build trust and confidence in AI's diagnostic recommendations.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Regarding the final responsibility for medical diagnoses, how do dermatologists perceive their role when AI is used?
|
|
|
Dermatologists serve a role as the people who make the judgment along with AI because it is unknown whether the AI's diagnosis is accurate or not.
|
Dermatologists are expected to use their judgment to make the final decision on what they think is the best and safest option for their patients. They should use the information given by AI and combine it with their rationality. They must pick the thing that they think is the responsible thing to do for the patients because they are not certain about the accuracy of AI's diagnosis.
|
5 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|